Drug Trial Radar · NCT03442985
An Efficacy and Safety Study of Palovarotene for the Treatment of MO
Last checked: Nov 20, 2026Latest source record: Aug 1, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
193
Actual
Start
Mar 22, 2018
Primary completion
Mar 24, 2020
Study completion Oct 30, 2020
Sponsor
- Lead sponsor
- Clementia Pharmaceuticals Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 22, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years, up to 14 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind, placebo-controlled study comparing the safety and efficacy of 2 dosage regimens of palovarotene versus placebo in preventing disease progression in pediatric subjects with multiple osteochondromas (MO).
Conditions
- Exostoses, Multiple Hereditary
Interventions
Palovarotene 2.5 mgDrug
Subjects received a weight-adjusted dose equivalent of 2.5 mg palovarotene, once daily, for up to 24 months.
Palovarotene 5.0 mgDrug
Subjects received a weight-adjusted dose equivalent of 5.0 mg palovarotene, once daily, for up to 24 months.
PlaceboOther
Subjects received placebo, once daily, for up to 24 months.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualized Rate of New Osteochondromas (OCs)Time frame: Month 12
Locations
31 sites in 12 countries. Site status is shown where the registry gives one.
Children's Orthopaedic Center
Los Angeles, California
Shriners Hospital for Children - Sacramento
Sacramento, California
University of California-San Francisco
San Francisco, California
Children's National Medical Center
Washington D.C., District of Columbia
The Paley Institute
West Palm Beach, Florida
Shriners Hospital for Children - Chicago
Chicago, Illinois
Johns Hopkins University
Baltimore, Maryland
Boston Children's Hospital
Boston, Massachusetts
Mayo Clinic - PPDS
Rochester, Minnesota
Shriners Hospitals for Children - Portland
Portland, Oregon
The Children's Hospital of Philadelphia (CHOP)
Philadelphia, Pennsylvania
Shriners Hospital for Children - Philadelphia
Philadelphia, Pennsylvania
Memorial Hermann Hospital
Houston, Texas
Westmead Children's Hospital
Westmead, New South Wales, Australia
UZ Antwerpen
Edegem, Antwerp, Belgium
Hospital for Sick Children
Toronto, Ontario, Canada
Centre Hospitalier Universitaire Sainte-Justine
Montreal, Quebec, Canada
Shriners Hospital for Children - Canada
Montreal, Quebec, Canada
Hôpital universitaire Necker - Enfants Malades
Paris, France
Hôpital des Enfants, CHU de Toulouse
Toulouse, France
Istituti Ortopedici Rizzoli
Bologna, Emilia-Romagna, Italy
Nagoya University Hospital
Nagoya, Aiti, Japan
Osaka University Hospital
Suita, Osaka, Japan
OLVG locatie Oost
Amsterdam, North Holland, Netherlands
Hospital Pediátrico de Coimbra
Coimbra, Portugal
Hospital Universitario La Paz
Madrid, Spain
Bezmialem Vakif University Medical Faculty Hospital
Istanbul, Turkey (Türkiye)
Ege University Medical Faculty Hospital
Bornova, İzmir, Turkey (Türkiye)
Evelina London Children's Hospital
London, United Kingdom
Royal Manchester Childrens Hospital
Manchester, United Kingdom
Royal National Orthopaedic Hospital
Stanmore, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.